Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent
Fatima Rashid,1 Matloob Ahmad,2 Usman Ali Ashfaq,1 Aamal A Al-Mutairi,3 Sami A Al-Hussain3 1Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan; 2Department of Chemistry, Government College University, Faisalabad, Pakistan; 3Department of Chemistry, Fa...
Published in: | Drug Design, Development and Therapy |
---|---|
Main Authors: | , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Dove Press
2022
|
Subjects: | |
Online Access: | https://www.dovepress.com/design-synthesis-and-pharmacological-evaluation-of-2-3-benzoyi-4-hydro-peer-reviewed-fulltext-article-DDDT |
id |
ftdovepress:oai:dovepress.com/79825 |
---|---|
record_format |
openpolar |
spelling |
ftdovepress:oai:dovepress.com/79825 2023-05-15T18:11:58+02:00 Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent Rashid,Fatima Ahmad,Matloob Ashfaq,Usman Ali Al-Mutairi,Aamal A Al-Hussain,Sami A 2022-11-22 text/html https://www.dovepress.com/design-synthesis-and-pharmacological-evaluation-of-2-3-benzoyi-4-hydro-peer-reviewed-fulltext-article-DDDT en eng Dove Press info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S379205 https://www.dovepress.com/design-synthesis-and-pharmacological-evaluation-of-2-3-benzoyi-4-hydro-peer-reviewed-fulltext-article-DDDT info:eu-repo/semantics/openAccess Drug Design Development and Therapy Original Research info:eu-repo/semantics/article 2022 ftdovepress https://doi.org/10.2147/DDDT.S379205 2022-12-27T23:38:53Z Fatima Rashid,1 Matloob Ahmad,2 Usman Ali Ashfaq,1 Aamal A Al-Mutairi,3 Sami A Al-Hussain3 1Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan; 2Department of Chemistry, Government College University, Faisalabad, Pakistan; 3Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi ArabiaCorrespondence: Usman Ali Ashfaq, Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan, Email ashfaqua@gcuf.edu.pk Sami A Al-Hussain, Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia, Email sahussain@imamu.edu.saPurpose: The present study is based on screening new and potent synthetic heterocyclic compounds as anti-diabetic drugs using various computational tools, lab experiments, and animal models.Methods: A potent synthetic compound 2-(3-benzoyl-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-1-(2-bromophenyl) acetamide (FA2) was checked against diabetes and screened via enzyme inhibition assays, enzyme kinetics against alpha-glucosidase and alpha-amylase. Protein–ligand interaction was analyzed via molecular docking and toxicological analysis via ADMET. Experimental animals were used to examine the compound FA2 safety, delivery, and check various biochemical tests related to diabetes like fasting glucose sugar, cholesterol, triglyceride, HbAc1, creatinine, and insulin level. Histography of liver, kidney, and pancreas was also performed.Results: Results showed that FA2 had binding energy of â€7.02 Kcal/mol and â€6.6 kcal/mol against αâ€glucosidase (PDB ID: 2ZE0) and αâ€amylase (PDB ID: 1B2Y), respectively. Moreover, in vitro enzyme inhibition assays and enzyme kinetics against αâ€glucosidase and αâ€amylase were performed, and FA2 showed IC50 at 5.17 ± 0.28 μM and 18.82 ± 0.89 μM concentrations against αâ€glucosidase and αâ€amylase, respectively. Kinetics studies showed that the FA2 ... Article in Journal/Newspaper sami Dove Medical Press Drug Design, Development and Therapy Volume 16 4043 4060 |
institution |
Open Polar |
collection |
Dove Medical Press |
op_collection_id |
ftdovepress |
language |
English |
topic |
Drug Design Development and Therapy |
spellingShingle |
Drug Design Development and Therapy Rashid,Fatima Ahmad,Matloob Ashfaq,Usman Ali Al-Mutairi,Aamal A Al-Hussain,Sami A Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
topic_facet |
Drug Design Development and Therapy |
description |
Fatima Rashid,1 Matloob Ahmad,2 Usman Ali Ashfaq,1 Aamal A Al-Mutairi,3 Sami A Al-Hussain3 1Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan; 2Department of Chemistry, Government College University, Faisalabad, Pakistan; 3Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi ArabiaCorrespondence: Usman Ali Ashfaq, Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan, Email ashfaqua@gcuf.edu.pk Sami A Al-Hussain, Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia, Email sahussain@imamu.edu.saPurpose: The present study is based on screening new and potent synthetic heterocyclic compounds as anti-diabetic drugs using various computational tools, lab experiments, and animal models.Methods: A potent synthetic compound 2-(3-benzoyl-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-1-(2-bromophenyl) acetamide (FA2) was checked against diabetes and screened via enzyme inhibition assays, enzyme kinetics against alpha-glucosidase and alpha-amylase. Protein–ligand interaction was analyzed via molecular docking and toxicological analysis via ADMET. Experimental animals were used to examine the compound FA2 safety, delivery, and check various biochemical tests related to diabetes like fasting glucose sugar, cholesterol, triglyceride, HbAc1, creatinine, and insulin level. Histography of liver, kidney, and pancreas was also performed.Results: Results showed that FA2 had binding energy of â€7.02 Kcal/mol and â€6.6 kcal/mol against αâ€glucosidase (PDB ID: 2ZE0) and αâ€amylase (PDB ID: 1B2Y), respectively. Moreover, in vitro enzyme inhibition assays and enzyme kinetics against αâ€glucosidase and αâ€amylase were performed, and FA2 showed IC50 at 5.17 ± 0.28 μM and 18.82 ± 0.89 μM concentrations against αâ€glucosidase and αâ€amylase, respectively. Kinetics studies showed that the FA2 ... |
format |
Article in Journal/Newspaper |
author |
Rashid,Fatima Ahmad,Matloob Ashfaq,Usman Ali Al-Mutairi,Aamal A Al-Hussain,Sami A |
author_facet |
Rashid,Fatima Ahmad,Matloob Ashfaq,Usman Ali Al-Mutairi,Aamal A Al-Hussain,Sami A |
author_sort |
Rashid,Fatima |
title |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
title_short |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
title_full |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
title_fullStr |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
title_full_unstemmed |
Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent |
title_sort |
design, synthesis and pharmacological evaluation of 2-(3-benzoyi-4-hydroxy-1,1-dioxido-2h-benzo[e][1,2]thiazin-2-yi)-n-(2-bromophenyl) acetamide as antidiabetic agent |
publisher |
Dove Press |
publishDate |
2022 |
url |
https://www.dovepress.com/design-synthesis-and-pharmacological-evaluation-of-2-3-benzoyi-4-hydro-peer-reviewed-fulltext-article-DDDT |
genre |
sami |
genre_facet |
sami |
op_relation |
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S379205 https://www.dovepress.com/design-synthesis-and-pharmacological-evaluation-of-2-3-benzoyi-4-hydro-peer-reviewed-fulltext-article-DDDT |
op_rights |
info:eu-repo/semantics/openAccess |
op_doi |
https://doi.org/10.2147/DDDT.S379205 |
container_title |
Drug Design, Development and Therapy |
container_volume |
Volume 16 |
container_start_page |
4043 |
op_container_end_page |
4060 |
_version_ |
1766184547946332160 |